According to the Prostate Cancer Foundation, prostate cancer is typically slow growing, often causing no symptoms until it reaches a more advanced stage. Once the disease begins to grow more rapidly or spreads outside the prostate, it can become a larger health problem. This aggressive type of prostate cancer can occur at any age, though more commonly in men over 50.
While screening is crucial for cancer detection there are some limits in screening for prostate cancer. Because the two tests most commonly used in screening, Blood Test (PSA) and Digital Rectal Exam (DRE) are not 100 percent accurate, early testing for prostate cancer can be difficult. Having both tests increases the accuracy. Men should be fully informed on the uncertainties, risks and potential benefits of cancer screening before making a decision to undergo testing for prostate cancer.
Factors that could increase a man’s risk of developing prostate cancer include age, family history and ethnicity. Age is the strongest factor in prostate cancer risk. Nearly two-thirds of prostate cancer occurs in men over age 65. Family history of the disease is another factor. Though the cause is unknown, prostate cancer is also found more commonly in African American men than in other races.
At New Jersey CyberKnife, prostate cancer is treated in five or fewer outpatient treatment sessions. If you or a loved one has been diagnosed with prostate cancer, contact us to learn more about CyberKnife treatment.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.